ArticleInternational journal of surgery (London, England)2026
Fibrin sealant for prophylaxis of cervical anastomotic leakage after McKeown esophagectomy for esophageal or esophagogastric junction cancer (PLACE030): a Phase III multicenter randomized clinical trial.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAnastomotic leakage (AL) is one of the most serious complications after esophagectomy, and previous studies have suggested that fibrin sealant (FS) might be beneficial in preventing AL. This study aimed to evaluate the efficacy and safety of FS in preventing AL.
methodsThis randomized controlled trial included 360 patients aged 18-75 years with resectable esophageal or esophagogastric junction cancer, clinically staged as T1-4aN0-3M0, from six centers in China. Surgery was performed using McKeown esophagectomy with circular stapled anastomosis combined with two-field lymphadenectomy. In the FS group, 2.5 ml of FS was applied circumferentially to the cervical anastomotic site. The primary endpoint was the incidence of AL within the first 3 months postoperatively.
resultsA total of 360 patients were recruited from February 2019 to May 2023, with 179 in the FS group and 181 in the control group. The incidence of AL was 7.3% in the FS group and 13.3% in the control group (P = 0.061). According to the subgroup analysis of patients who underwent upfront surgery without neoadjuvant treatment, the incidence of AL in the FS group was numerically lower without statistical significance [FS group: 5.8% vs. control group: 15.1%; P = 0.046, RR = 0.385 (95% CI, 0.143-1.032)]. The incidence of postoperative complications was similar between the two groups (FS group: 41.6% vs. control group: 48.9%; P = 0.163).
conclusionsIntraoperative sealing with porcine FS did not significantly reduce the incidence of cervical AL. For patients who undergo upfront esophagectomy, the potential protective effect of FS needs further studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.